Free Trial

Colgate-Palmolive (NYSE:CL) Stock Unloaded Rep. Lisa C. McClain

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Rep. Lisa C. McClain sold shares of Colgate-Palmolive Company for between $1,001 and $15,000 on June 24th, which was disclosed in a filing on August 13th.
  • Colgate-Palmolive's stock recently traded at $85.02, with a market cap of $68.71 billion and a P/E ratio of 23.88; the stock has a 52-week range of $82.40 to $109.30.
  • The company reported a quarterly earnings of $0.92 per share, exceeding estimates, and recently announced a quarterly dividend of $0.52 per share.
  • Want stock alerts on Colgate-Palmolive? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on June 24th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Colgate-Palmolive Trading Up 1.7%

NYSE:CL traded up $1.4590 during mid-day trading on Tuesday, hitting $85.7190. 4,548,147 shares of the company's stock were exchanged, compared to its average volume of 5,225,339. The company has a 50 day simple moving average of $88.07 and a 200-day simple moving average of $89.98. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The firm has a market capitalization of $69.28 billion, a P/E ratio of 24.08, a PEG ratio of 4.42 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the company earned $0.91 EPS. The firm's revenue was up 1.0% compared to the same quarter last year. As a group, research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.4%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CL shares. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Barclays lifted their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a report on Monday, August 4th. Finally, UBS Group lowered their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $98.92.

Get Our Latest Stock Report on CL

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Westend Capital Management LLC lifted its position in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares during the period. Westside Investment Management Inc. increased its stake in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock valued at $26,000 after purchasing an additional 130 shares in the last quarter. Cornerstone Planning Group LLC increased its stake in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after purchasing an additional 287 shares in the last quarter. Saudi Central Bank bought a new stake in Colgate-Palmolive during the 1st quarter valued at $29,000. Finally, Vermillion & White Wealth Management Group LLC increased its stake in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock valued at $30,000 after purchasing an additional 155 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines